Scientists find molecular switch to revert cancer cells to normal

Scientists at KAIST have developed a computational method called REVERT that identifies molecular switches capable of reverting cancer cells to normal cells by analyzing gene activity and simulating cellular states, with promising results in colorectal organoids and potential applications across various cancer types and regenerative medicine.